- Home
- PFE vs SNY Comparison
PFE vs SNY Comparison
Compare PFE & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFE
- SNY
- Stock Information
- Founded
- PFE 1849
- SNY 1994
- Country
- PFE United States
- SNY France
- Employees
- PFE N/A
- SNY N/A
- Industry
- PFE Biotechnology: Pharmaceutical Preparations
- SNY Biotechnology: Pharmaceutical Preparations
- Sector
- PFE Health Care
- SNY Health Care
- Exchange
- PFE Nasdaq
- SNY Nasdaq
- Market Cap
- PFE 140.8B
- SNY 113.4B
- IPO Year
- PFE N/A
- SNY N/A
- Fundamental
- Price
- PFE $24.04
- SNY $46.97
- Analyst Decision
- PFE Hold
- SNY Buy
- Analyst Count
- PFE 12
- SNY 4
- Target Price
- PFE $29.36
- SNY $61.50
- AVG Volume (30 Days)
- PFE 41.5M
- SNY 2.7M
- Earning Date
- PFE 10-28-2025
- SNY 10-24-2025
- Dividend Yield
- PFE 7.16%
- SNY 3.40%
- EPS Growth
- PFE N/A
- SNY 118.56
- EPS
- PFE 1.89
- SNY 8.65
- Revenue
- PFE $63,833,000,000.00
- SNY $53,714,621,258.00
- Revenue This Year
- PFE $0.35
- SNY $1.53
- Revenue Next Year
- PFE N/A
- SNY $7.06
- P/E Ratio
- PFE $12.69
- SNY $5.43
- Revenue Growth
- PFE 13.53
- SNY 15.65
- 52 Week Low
- PFE $20.92
- SNY $44.73
- 52 Week High
- PFE $30.43
- SNY $60.12
- Technical
- Relative Strength Index (RSI)
- PFE 42.35
- SNY 43.02
- Support Level
- PFE $23.68
- SNY $46.50
- Resistance Level
- PFE $24.86
- SNY $47.69
- Average True Range (ATR)
- PFE 0.45
- SNY 0.68
- MACD
- PFE -0.12
- SNY -0.18
- Stochastic Oscillator
- PFE 25.00
- SNY 36.14
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.